Analysis
Customs
1 min read
India Leverages Refineries, Duty Cuts to Ensure Medicine Supply
Full Story
India reduced customs duties to zero on 40 petrochemical products starting April 1, 2026, and is leveraging local refineries to maintain medicine supplies amidst West Asia crisis-induced global supply chain disruptions.
Background
The West Asia crisis has disrupted global supply chains, threatening the availability and affordability of essential medicines in India, which relies on imports routed through Kandla, Gujarat.
Key Analysis
Refinery realignment
Bharat Petroleum and other domestic refiners are reallocating production to supply propylene, ammonia, and methanol.
Customs duty cuts
Zero customs duty on 40 petrochemicals eases costs for manufacturers.
Stable drug prices
Despite global API and solvent shortages, drug prices in India remain stable.
Bottom Line
These measures aim to ensure the continued availability of essential medicines and protect Indian consumers from price spikes.
Watch For
Monitor supply chain stabilization and the impact of relaxed quality norms on medicine quality.
Related Articles
09 Apr 2026
· Customs
Customs Duty and AIDC Exemptions Granted for Specific Imports
08 Apr 2026
· Customs
Digital Platform Now Mandatory for Certificate of Origin Issuance; Manual Processing Banned
07 Apr 2026
· Customs
DGFT: Only Authorized Agencies Can Issue Certificates of Origin
07 Apr 2026
· Customs
Employee Secondment Subject to Service Tax: CESTAT Affirms Airbus Demand
07 Apr 2026
· Customs